AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
216.77
+0.88 (0.41%)
At close: Nov 5, 2025, 4:00 PM EST
216.70
-0.07 (-0.03%)
After-hours: Nov 5, 2025, 7:52 PM EST
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
$1,084,436
Profits / Employee
$42,691
Market Cap
383.12B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Jan 31, 2024 | 50,000 | 0 | - |
| Jan 31, 2023 | 50,000 | 0 | - |
| Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
| Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
| Jan 31, 2020 | 30,000 | 0 | - |
| Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
| Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
| Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
| Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
| Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
| Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
| Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABBV News
- 2 days ago - Biotech is back. Here's why these rallying stocks belong in your portfolio now. - Market Watch
- 4 days ago - ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November - Seeking Alpha
- 4 days ago - Best Dividend Aristocrats For November 2025 - Seeking Alpha
- 5 days ago - AbbVie Inc. (ABBV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend - Benzinga
- 5 days ago - AbbVie: Why Q3 Confirms Its Immunology Dominance - Seeking Alpha
- 5 days ago - AbbVie Lifts Profit Outlook as Sales Rise - WSJ
- 5 days ago - AbbVie Beats Third-Quarter Estimates. There's More to the Drugmaker's Earnings. - Barrons